‹ Screener

Cellebrite DI Ltd.

CLBT · Services-Prepackaged Software · EDGAR filings ↗

Reference price $13.10 — last insider sale, 2026-05-21 (estimated from the dated SEC Form 4 price — not a live quote)

Grade

B76

Digital-forensics / investigative-analytics SaaS — profitable with strong free cash flow and growth.

Strengths

Risks

Notable findings

Key metrics

Gross margin
84.2%
Operating margin
14.0%
Net margin
16.5%
Return on equity
16.2%
Return on assets
8.3%
Revenue growth (QoQ)
18.6%
Current ratio
1.6×
Free cash flow
$160M
EBITDA
$78M
Tangible book value
$283M
Cash & investments
$374M
Stock comp / revenue
9.4%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-05-21GEE DAVID NICHOLASSell2.2K$13.10
2026-05-21GEE DAVID NICHOLASSell3.4K$13.15
2026-05-18Jewell MarcusSell13K$12.77
2026-05-12GEE DAVID NICHOLASSell228$13.01
2026-05-12Jewell MarcusSell383$13.01
2026-05-12Ramji ShivenGrant424K

All non-derivative Form 4 activity (SEC), newest first.

Recent filings

FormFiledPeriodAccession
20-F2026-03-032025-12-310001628280-26-013790 ↗
20-F2025-03-182024-12-310001628280-25-013334 ↗
20-F2024-03-212023-12-310001854587-24-000018 ↗
20-F2023-04-272022-12-310001628280-23-013355 ↗
20-F2022-03-292021-12-310001854587-22-000004 ↗